Optimal management of cancer anorexia–cachexia syndrome

References

• EvansWJMorleyJEArgilésJCachexia: a new definitionClin Nutr200827679379918718696
   PubMed Web of Science ®Google Scholar
• WarrenSThe immediate cause of death in cancerAm J Med Sci1932184610613
   Google Scholar
• MulliganKSchambelanMAnabolic treatment with GH, IGF-I, or anabolic steroids in patients with HIV-associated wastingInt J Cardiol200285115115912163220
   PubMed Web of Science ®Google Scholar
• AnkerSDSharmaRThe syndrome of cardiac cachexiaInt J Cardiol2002851516612163209
   PubMed Web of Science ®Google Scholar
• ArgilésJMÁlvarezBLópez-SorianoFJThe metabolic basis of cancer cachexiaMed Res Rev19971754774989276862
   PubMed Web of Science ®Google Scholar
• ArgilésJMLópez-SorianoFJWhy do cancer cells have such a high glycolytic rate?Med Hypotheses19903221511552142979
   PubMed Web of Science ®Google Scholar
• ArgilésJMLópez-SorianoFJBusquetsSMechanisms to explain wasting of muscle and fat in cancer cachexiaCurr Opin Support Palliat Care20071429329818685378
   PubMedGoogle Scholar
• ZeiselSHRegulation of “nutraceuticals”Science199928554351853185510515789
   PubMed Web of Science ®Google Scholar
• RamosEJMiddletonFALavianoAEffects of omega-3 fatty acid supplementation on tumor-bearing ratsJ Am Coll Surg2004199571672315501111
   PubMed Web of Science ®Google Scholar
• ArgilésJMLópez-SorianoFJBusquetsSNovel approaches to the treatment of cachexiaDrug Discov Today2008131–2737818190867
   PubMed Web of Science ®Google Scholar
• De WysWWorking conference on anorexia and cachexia of neoplastic diseaseCancer Res19703011281628185274947
   PubMed Web of Science ®Google Scholar
• LoprinziCLMichalakJCSchaidDJPhase III evaluation of megestrol acetate as therapy for patients with cancer anorexia and/or cachexiaJ Clin Oncol19931147627678478668
   PubMed Web of Science ®Google Scholar
• NeriBGarosVLIIntiniCEffect of medroxyprogesterone acetate on the quality of life of the oncologic patient: a multicentric cooperative studyAnticancer Drugs1997854594659215608
   PubMed Web of Science ®Google Scholar
• MccarthyHCrowderRDrydenSWilliamsGMegestrol acetate stimulates food and water intake in the rat: effects on regional hypothalamic neuropeptide Y concentrationsEur J Pharmacol19942651–2991027883035
   PubMed Web of Science ®Google Scholar
• LoprinziCLSchaidDJDoseAMBurnhamNLJensenMDBodycomposition changes in patients who gain weight while receiving megestrol acetateJ Clin Oncol19931111521548418227
   PubMed Web of Science ®Google Scholar
• TomískaMTomiskováMSalajkaFAdamZVorlícekJPalliative treatment of cancer anorexia with oral suspension of megestrol acetateNeoplasma200350322723312937858
   PubMed Web of Science ®Google Scholar
• Les’niakWBałaMJaeschkeRKrzakowskiMEffects of megestrol acetate in patients with cancer anorexia-cachexia syndrome-a systematic review and meta-analysisPol Arch Med Wewn20081181163664419140567
   PubMedGoogle Scholar
• MitchelsonFPharmacological agents affecting emesis: a reviewDrugs19924332953151374316
   PubMed Web of Science ®Google Scholar
• SrivastavaMDSrivastavaBIBrouhardBDelta9 tetrahydrocannabinol and cannabidiol alter cytokine production by human immune cellsImmunopharmacology19984031791859858061
   PubMed Web of Science ®Google Scholar
• FacchinettiFDel GiudiceEFuregatoSPassarottoMLeonACannabinoids ablate release of TNFalpha in rat microglial cells stimulated with lypopolysaccharideGlia200341216116812509806
   PubMed Web of Science ®Google Scholar
• StrasserFLuftnerDPossingerKComparison of orally administered cannabis extract and delta-9-tetrahydrocannabinol in treating patients with cancer-related anorexia–cachexia syndrome: a multicenter, phase III, randomized, double-blind, placebo controlled clinical trial from the Cannabis-In-Cachexia-Study-GroupJ Clin Oncol200624213394340016849753
   PubMed Web of Science ®Google Scholar
• Rossi-FanelliFCangianoCIncreased availability of tryptophan in brain as a common pathogenic mechanism for anorexia associated with different diseasesNutrition1991753643671804475
   PubMed Web of Science ®Google Scholar
• KardinalCGLoprinziCLSchaidDJA controlled trial of cyproheptadine in cancer patients with anorexiaCancer19906512265726622187585
   PubMed Web of Science ®Google Scholar
• CoulurisMMayerJLFreyerDRSandlerEXuPKrischerJPThe effect of cyproheptadine hydrochloride (periactin) and megestrol acetate (megace) on weight in children with cancer/treatment-related cachexiaJ Pediatr Hematol Oncol2008301179179718989154
   PubMed Web of Science ®Google Scholar
• SarcevTSecenNSaboAPovazanDInfluence of dexamethasone on appetite and bodyweight in lung cancer patientsMed Pregl20086111–1257157519368274
   PubMedGoogle Scholar
• DerogatisLMacdonaldRPsychopharmacologic applications to cancerCancer1982509196819737127274
   PubMed Web of Science ®Google Scholar
• ViganoAWatanabeSBrueraEAnorexia and cachexia in advanced cancer patientsCancer Surv199421991158565002
   PubMedGoogle Scholar
• DixitVDSchafferEMPyleRSGhrelin inhibits leptin- and activation-induced proinflammatory cytokine expression by human monocytes and T cellsJ Clin Invest20041141576615232612
   PubMed Web of Science ®Google Scholar
• NagayaNKojimaMKangawaKGhrelin, a novel growth hormonereleasing peptide, in the treatment of cardiopulmonary-associated cachexiaIntern Med200645312713416508225
   PubMed Web of Science ®Google Scholar
• GarciaJMPolvinoWJEffect on bodyweight and safety of RC-1291, a novel, orally available ghrelin mimetic and growth hormone secretagogue: results of a phase I, randomized, placebo-controlled, multipledose study in healthy volunteersOncologist200712559460017522248
   PubMed Web of Science ®Google Scholar
• ShimizuHInoueKMoriMThe leptin-dependent and -independent melanocortin signaling system: regulation of feeding and energy expenditureJ Endocrinol200719311917400797
   PubMed Web of Science ®Google Scholar
• ScarlettJMMarksDLThe use of melanocortin antagonists in cachexia of chronic diseaseExpert Opin Investig Drugs2005141012331239
   PubMed Web of Science ®Google Scholar
• DeboerMDMarksDLTherapy insight: use of melanocortin antagonists in the treatment of cachexia in chronic diseaseNat Clin Pract Endocrinol Metab20062845946616932335
   PubMedGoogle Scholar
• EvansRDArgilésJMWilliamsonDHMetabolic effects of tumor necrosis factor-α (cachectin) and interleukin-1Clin Sci19897743573642680232
   PubMed Web of Science ®Google Scholar
• YamamotoNKawamuraINishigakiFEffect of FR143430, a novel cytokine suppressive agent, on adenocarcinoma colon-26-induced cachexia in miceAnticancer Res1998181A1391449568068
   PubMed Web of Science ®Google Scholar
• BalazsCKissEImmunological aspects of the effect of pentoxifylline (trental)Acta Microbiol Immunol Hung19944121211267804717
   PubMedGoogle Scholar
• GoldbergRMLoprinziCLMailliardJAPentoxifylline for treatment of cancer anorexia and cachexia? A randomized, double-blind, placebo-controlled trialJ Clin Oncol19951311285628597595749
   PubMed Web of Science ®Google Scholar
• SampaioEPSarnoENGalillyRCohnZAKaplanGThalidomide selectively inhibits tumor necrosis factor-α production in stimulated human monocytesJ Exp Med199117336997031997652
   PubMed Web of Science ®Google Scholar
• SampaioEPKaplanGMirandaAThe influence of thalidomide on the clinical and immunological manifestation of erithema nodosum leprosumJ Infect Dis199316824084148335978
   PubMed Web of Science ®Google Scholar
• GordonJNTrebbleTMEllisRDDuncanHDJohnsTGogginPMThalidomide in the treatment of cancer cachexia: a randomised placebo controlled trialGut200554444744815753523
   PubMed Web of Science ®Google Scholar
• CarbóNCostelliPTessitoreLAnti-TNF-α treatment interferes with changes in lipid metabolism in a tumor cachexia modelClin Sci19948733493557955912
   PubMed Web of Science ®Google Scholar
• CostelliPCarbóNTessitoreLTNF-α mediates changes in tissue protein turnover in a rat cancer cachexia modelJ Clin Invest1993926278327898254032
   PubMed Web of Science ®Google Scholar
• JatoiADakhilSRNguyenPLA placebo-controlled double blind trial of etanercept for the cancer anorexia/weight loss syndrome: results from N00C1 from the North central cancer treatment groupCancer200711061396140317674351
   PubMed Web of Science ®Google Scholar
• YasumotoKMukaidaNHaradaAMolecular analysis of the cytokine network involved in cachexia in colon 26 adenocarcinomabearing miceCancer Res19955549219277850809
   PubMed Web of Science ®Google Scholar
• StrassmannGFongMFreterCEWindsorSD’AlessandroFNordanRPSuramin interfers with interleukin-6 receptor binding in vitro and inhibits colon-26-mediated experimental cancer cachexia in vivoJ Clin Invest1993925215221598227330
   PubMed Web of Science ®Google Scholar
• MatthysPHeremansHOpdenakkerGBilliauAAnti-interferon-γ antibody treatment, growth of Lewis lung tumors in mice and tumorassociated cachexiaEur J Cancer19912721821871827286
   PubMed Web of Science ®Google Scholar
• CostelliPLloveraMCarbóNGarcía-MartínezCLópez-SorianoFJArgilésJMInterleukin-1 receptor antagonist (IL-1ra) is unable to reverse cachexia in rats bearing an ascites hepatoma (Yoshida AH-130)Cancer Lett1995951–233387656241
   PubMed Web of Science ®Google Scholar
• MonkJPPhillipsGWaiteRAssessment of TNF-α blockade as an intervention to improve tolerability of dose-intensive chemotherapy in cancer patientsJ Clin Oncol200624121852185916622259
   PubMed Web of Science ®Google Scholar
• QuinnLSHaugkKLGrabsteinKHInterleukin-15: a novel anabolic cytokine for skeletal muscleEndocrinology19951368366936727628408
   PubMed Web of Science ®Google Scholar
• CarbóNLópez-SorianoJCostelliPInterleukin-15 mediates reciprocal regulation of adipose and muscle mass: a potential role in bodyweight controlBiochim Biophys Acta200115261172411287118
   PubMed Web of Science ®Google Scholar
• FiguerasMBusquetsSCarbóNInterleukin-15 is able to suppress the increased DNA fragmentation associated with muscle wasting in tumor-bearing ratsFEBS Lett20045691–320120615225634
   PubMed Web of Science ®Google Scholar
• BusquetsSFiguerasMTMeijsingSInterleukin-15 decreases proteolysis in skeletal muscle: a direct effectInt J Mol Med200516347147616077957
   PubMed Web of Science ®Google Scholar
• StorerTWWoodhouseLJSattlerFA randomized, placebocontrolled trial of nandrolone decanoate in human immunodeficiency virus-infected men with mild to moderate weight loss with recombinant human growth hormone as active reference treatmentJ Clin Endocrinol Metab20059084474448215914526
   PubMed Web of Science ®Google Scholar
• EvansWSmithMRMorleyJEOstarine increases lean body mass and improves physical performance in healthy elderly subjects: implications for cancer cachexia patients. ASCO Annual Meeting Proceedings Part IJ Clin Oncol200725 abstr #9119.
   Web of Science ®Google Scholar
• BusquetsSFiguerasMTFusterGAnticachectic effects of formoterol: a drug for potential treatment of muscle wastingCancer Res200464186725673115374990
   PubMed Web of Science ®Google Scholar
• LainscakMKeberIAnkerSDBody composition changes in patients with systolic heart failure treated with beta blockers: a pilot studyInt J Cardiol2006106331932216337039
   PubMed Web of Science ®Google Scholar
• RoseDPConnollyJMEffects of dietary omega-3 fatty acids on human breast cancer growth and metastases in nude miceJ Natl Cancer Inst19938521174317478411258
   PubMedGoogle Scholar
• TisdaleMJMechanism of lipid mobilization associated with cancer cachexia: interaction between the polyunsaturated fatty acid, eicosapentaenoic acid, and inhibitory guanine nucleotideregulatory proteinProstaglandins Leukot Essent Fatty Acids19934811051098380931
   PubMed Web of Science ®Google Scholar
• FearonKCVon MeyenfeldtMFMosesAGEffect of a protein and energy dense N-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomized double blind trialGut200352101479148612970142
   PubMed Web of Science ®Google Scholar
• FearonKCBarberMDMosesAGDouble-blind, placebo-controlled, randomized study of eicosapentaenoic acid diester in patients with cancer cachexiaJ Clin Oncol200624213401340716849754
   PubMed Web of Science ®Google Scholar
• DeweyABaughanCDeanTHigginsBJohnsonIEicosapentaenoic acid (EPA, an omega-3 fatty acid from fish oils) for the treatment of cancer cachexiaCochrane Database Syst Rev2007241CD00459717253515
   PubMed Web of Science ®Google Scholar
• MehraMRLavieCJVenturaHOMilaniRVFish oils produce antiinflammatory effects and improve bodyweight in severe heart failureJ Heart Lung Transplant200625783483816818127
   PubMed Web of Science ®Google Scholar
• GuarcelloMRisoSBuosiRd’AndreaFEPA-enriched oral nutritional support in patients with lung cancer: effects on nutritional status and quality of lifeNutr Ther and Metab200624168175
   Google Scholar
• ReadJABealePJVolkerDHSmithNChildsAClarkeSJNutrition intervention using an eicosapentaenoic acid (EPA)-containing supplement in patients with advanced colorectal cancer. Effects on nutritional and inflammatory status: a phase II trialSupport Care Cancer200715330130717021855
   PubMed Web of Science ®Google Scholar
• Van der MeijBSLanguisJAVan AdrichemVSpreeuwenbergMDSmitEFVan LeeuwenPAA double blind randomized controlled trial on oral nutritional supplementation of omega-3 fatty acids in non-small cell lung carcinomaClin Nutr Suppl20083111
   Google Scholar
• BayramIErbeyFCelikNNelsonJLTanyeliAThe use of a protein and energy dense eicosapentaenoic acid containing supplement for malignancy-related weight loss in childrenPediatr Blood Cancer200952557157419090549
   PubMed Web of Science ®Google Scholar
• RyanAMReynoldsJVHealyLEnteral nutrition enriched with eicosapentaenoic acid (EPA) preserves lean body mass following esophageal cancer surgery: results of a double-blinded randomized controlled trialAnn Surg2009249335536319247018
   PubMed Web of Science ®Google Scholar
• CerchiettiLCNaviganteAHCastroMAEffects of eicosapentaenoic and docosahexaenoic n-3 fatty acids from fish oil and preferential Cox-2 inhibition on systemic syndromes in patients with advanced lung cancerNutr Cancer2007591142017927497
   PubMed Web of Science ®Google Scholar
• De WysWDManagement of cancer cachexiaSemin Oncol19851244524603936180
   PubMed Web of Science ®Google Scholar
• TayekJABistrianBRHehirDJMartinRMoldawerLLBlackburnGLImproved protein kinetics and albumin synthesis by branched-chain amino acid-enriched total parenteral nutrition in cancer cachexiaCancer19865811471573085914
   PubMed Web of Science ®Google Scholar
• HunterDCWeintraubMBlackburnGLBistrianBRBranched-chain amino acids as the protein component of parenteral nutrition in cancer cachexiaBr J Surg19897621491532495147
   PubMed Web of Science ®Google Scholar
• CangianoCLavianoAMeguidMMEffects of administration of oral branched-chain amino acids on anorexia and caloric intake in cancer patientsJ Natl Cancer Inst19968885505528606384
   PubMedGoogle Scholar
• BusquetsSÁlvarezBLópez-SorianoFJArgilésJMBranched-chain amino acids: a role in skeletal muscle proteolysis in catabolic states?J Cell Physiol2002191328328912012323
   PubMed Web of Science ®Google Scholar
• MeguidMMMuscaritoliMBeverlyJLYangZJCangianoCRossi-FanelliFThe early cancer anorexia paradigm: changes in plasma free tryptophan and feeding indexesJ Parent Enteral Nutr1992166S56S59
   Web of Science ®Google Scholar
• FernstromJDDietary effects on brain serotonin synthesis: relationship to appetite regulationAm J Clin Nutr1985425107210824061359
   PubMed Web of Science ®Google Scholar
• SoubaWWGlutamine and cancerAnn Surg199321867157288257221
   PubMed Web of Science ®Google Scholar
• RiveraSAzcón-BietoJLópez-SorianoFJMiralpeixMArgilésJMAmino acid metabolism in tumor-bearing miceBiochem J198824924434493342022
   PubMed Web of Science ®Google Scholar
• ChenMKSalloumRMAustgenTRTumor regulation of hepatic glutamine metabolismJ Parent Enteral Nutr1991152159164
   Web of Science ®Google Scholar
• ZieglerTRYoungLSBenfellKClinical and metabolic efficacy of glutamine-supplemented parenteral nutrition after bone marrow transplantationAnn Intern Med1992116108218281567096
   PubMed Web of Science ®Google Scholar
• KlimbergVSNwokediEHutchinsLFGlutamine facilitates chemotherapy while reducing toxicityJ Parent Enteral Nutr1992166S83S87
   Web of Science ®Google Scholar
• LavianoARenvyleTYangZJFrom laboratory to bedside: new strategies in the treatment of malnutrition in cancer patientsNutrition19961221121228724382
   PubMed Web of Science ®Google Scholar
• MayPEBarberAD’OlimpioJTHourihaneAAbumradNNReversal of cancer-related wasting using oral supplementation with a combination of beta-hydroxy-beta-methylbutyrate, arginine, and glutamineAm J Surg2002183447147911975938
   PubMed Web of Science ®Google Scholar
• DrögeWGrossAHackVRole of cysteine and glutathione in HIV infection and cancer cachexia: therapeutic intervention with N-acetylcysteineAdv Pharmacol1997385816008895825
   PubMedGoogle Scholar
• HackVGrossAKinscherfRAbnormal glutathione and sulfate levels after interleukin-6 treatment in tumor-induced cachexiaFASEB J19961010121912268751725
   PubMed Web of Science ®Google Scholar
• KikawaYNarumiyaSFukushimaMWakatsukaHHayaishiO9-Deoxy-delta 9, delta 12–13,14-dihydroprostaglandin D2, a metabolite of prostaglandin D2 formed in human plasmaProc Natl Acad Sci U S A1984815131713216584883
   PubMed Web of Science ®Google Scholar
• FischerSMFurstenbergerGMarksFSlagaTJEvents associated with mouse skin tumor promotion with respect to arachidonic acid metabolism: a comparison between SENCAR and NMRI miceCancer Res19874712317431793107806
   PubMed Web of Science ®Google Scholar
• WilliamsEDKarimSMMSandlerMProstaglandin secretion by medullary carcinoma of the thyroid. A possible cause of the associated diarrhoeaLancet19681753222234169067
   PubMed Web of Science ®Google Scholar
• Homem-de-Bittencourt JuniorPIPontieriVCuriRRLopesOUEffects of aspirin-like drugs on Walker 256 tumor growth and cachexia in rats. BrazJ Med Biol Res198922810391042
   Web of Science ®Google Scholar
• MccarthyDODaunJMThe effects of cyclooxigenase inhibitors on tumor-induced anorexia in ratsCancer19937124864928422643
   PubMed Web of Science ®Google Scholar
• HusseyHJTisdaleMJEffect of the specific cyclooxygenase-2 inhibitor meloxicam on tumor growth and cachexia in a murine modelInt J Cancer20008719510010861458
   PubMed Web of Science ®Google Scholar
• LaiVGeorgeJRicheyLResults of a pilot study of the effects of celecoxib on cancer cachexia in patients with cancer of the head, neck, and gastrointestinal tractHead Neck2008301677417615567
   PubMed Web of Science ®Google Scholar
• CahlinCGelinJDelbroDLonnrothCDoiCLundholmKEffect of cyclooxygenase and nitric oxide synthase inhibitors on tumor growth in mouse tumor models with and without cancer cachexia related to prostanoidsCancer Res20006061742174910749148
   PubMed Web of Science ®Google Scholar
• AnkerSDNegassaACoatsAJPrognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational studyLancet200336193631077108312672310
   PubMed Web of Science ®Google Scholar
• AdigunAQAjayiAAThe effects of enalapril-digoxin-diuretic combination therapy on nutritional and anthropometric indices in chronic congestive heart failure: preliminary findings in cardiac cachexiaEur J Heart Fail20013335936311378008
   PubMed Web of Science ®Google Scholar
• ZhaoSPXieXMCaptopril inhibits the production of tumor necrosis factor-alpha by human mononuclear cells in patients with congestive heart failureClin Chim Acta20013041–2859011165202
   PubMed Web of Science ®Google Scholar
• SandersPMRussellSTTisdaleMJAngiotensin II directly induces muscle protein catabolism through the ubiquitin-proteasome proteolytic pathway and may play a role in cancer cachexiaBr J Cancer200593442543416052213
   PubMed Web of Science ®Google Scholar
• LindholmEDanerydPKörnerUHyltanderAFouladiunMLundholmKEffects of recombinant erythropoietin in palliative treatment of unselected cancer patientsClin Cancer Res200410206855686415501962
   PubMed Web of Science ®Google Scholar
• KanzakiMSodaKGinPTKaiTKonishiFKawakamiMErythropoietin attenuates cachectic events and decreases production of interleukin-6, a cachexia-inducing cytokineCytokine200532523423916338141
   PubMed Web of Science ®Google Scholar
• AgtereschHJDagneliePCVan der GaastAStijnenTWilsonJHRandomized clinical trial of adenosine 5′-triphosphate in patients with advanced non-small-cell lung cancerJ Natl Cancer Inst200092432132810675381
   PubMedGoogle Scholar
• AgtereschHJRietveldTKerkhofsLGVan den BergJWWilsonJHDagneliePCBeneficial effects of adenosine triphosphate on nutritional status in advanced lung cancer patients: a randomized clinical trialJ Clin Oncol200220237137811786563
   PubMed Web of Science ®Google Scholar
• LeeDHGoldbergALProteasome inhibitors: valuable new tools for cell biologistsTrends Cell Biol19988103974039789328
   PubMed Web of Science ®Google Scholar
• von HaehlingSGenth-ZotzSAnkerSDVolkHDCachexia: a therapeutic approach beyond cytokine antagonismInt J Cardiol200285117318312163222
   PubMed Web of Science ®Google Scholar
• BodineSCLatresEBaumhueterSIdentification of ubiquitin ligases required for skeletal muscle atrophyScience200129455471704170811679633
   PubMed Web of Science ®Google Scholar
• McFarlaneCPlummerEThomasMMyostatin induces cachexia by activating the ubiquitin proteolytic system through an NF-κB-independent, FoxO1-dependent mechanismJ Cell Physiol2006209250151416883577
   PubMed Web of Science ®Google Scholar
• IsfortRJWangFTscheinerMDiscovery of corticotropin releasing factor 2 receptor selective sauvagine analogues for treatment of skeletal muscle atrophyJ Med Chem200548126226515634020
   PubMed Web of Science ®Google Scholar
• ArgilésJMFiguerasMAmetllerEEffects of CRF2R agonist on tumor growth and cachexia in mice bearing the Lewis lung carcinomaMuscle Nerve200837219019517912749
   PubMed Web of Science ®Google Scholar
• van NorrenKKeglerDArgilésJMDietary supplementation with a specific combination of high protein, leucine, and fish oil improves muscle function and daily activity in tumor-bearing cachectic miceBr J Cancer2009100571372219259092
   PubMed Web of Science ®Google Scholar
• MantovaniGMacciòAMadedduCA phase II study showing efficacy and safety in patients with cancer-related anorexia/cachexia and oxidative stressCancer Epidemiol Biomarkers Prev20061551030103416702388
   PubMed Web of Science ®Google Scholar
• ArgilésJMAlmendroVBusquetsSLópez-SorianoFJThe pharmacological treatment of cachexiaCurr Drug Targets20045326527715058312
   PubMed Web of Science ®Google Scholar